Grants for Public and State controlled institutions of higher education - Health

This funding opportunity provides financial support to nonprofit organizations and government entities to oversee and enhance the national 988 Suicide & Crisis Lifeline, ensuring effective crisis response services across the country.

This funding opportunity provides support for high-risk clinical trials focused on infectious, immunologic, and allergic diseases, encouraging innovative research that can lead to new treatments and therapies.

The purpose of the Mentored Quantitative Research Career Development Award (K25) is to attract to NIH-relevant research those investigators whose quantitative science and engineering research has thus far not been focused primarily on questions of health and disease. The K25 award will provide support and "protected time" for a period of supervised study and research for productive professionals with quantitative (e.g., mathematics, statistics, economics, computer science, imaging science, informatics, physics, chemistry) and engineering backgrounds to integrate their expertise with NIH-relevant research. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor. Applicants proposing a clinical trial or an ancillary clinical trial as lead investigator, should apply to the companion FOA ().

This initiative provides funding to rural health organizations in Nebraska to improve education and navigation services for individuals managing chronic diseases, particularly in underserved areas.

This funding opportunity supports U.S.-based cancer research institutions to enhance their research infrastructure and collaborative efforts in cancer prevention, treatment, and care.

This funding opportunity supports research projects aimed at reducing stigma related to HIV/AIDS in low- and middle-income countries, with a focus on improving health outcomes for affected populations.

This Annual Program Statement (APS) publicizes the intention of the United States Government (USG), as represented by the USAID Bureau for Global Health (GH), to fund one or multiple awards to address the overarching APS program purpose to strengthen the generation and utilization of social and behavior change (SBC) evidence to improve the uptake and continuation of healthy behaviors. This APS document outlines the goal, purpose, expected results, and priorities of the Social and Behavior Change (SBC) Research project, and may result in multiple awards issued under subsequent APS Rounds. Note: when referencing SBC Research in this document, it is referring to the full portfolio of possible awards under this overall purpose. This document is an umbrella APS and will not solicit concept papers or applications. Prospective applicants will be provided a fair opportunity to develop and submit competitive concept papers to USAID for potential funding via Rounds under this APS.

This funding opportunity provides financial support for researchers to conduct early-phase clinical trials aimed at developing new treatments or diagnostic tools for heart, lung, blood, and sleep disorders in both adults and children.

This funding opportunity provides financial support to institutions and organizations for creating a centralized data hub and coordinating center that will enhance innovative research methodologies in biomedical science, focusing on alternatives to traditional animal models.

Addressing the Impact of Syndemics on the Health of People with HIV and Diseases and Conditions within the Missions of NIDDK and NHLBI (R01 Clinical Trial Optional)

This funding opportunity is designed to support non-profit organizations in expanding and implementing proven falls prevention programs for older adults, focusing on effective strategies for broader adoption within community and clinical settings.

This funding opportunity provides financial support for researchers to conduct secondary analyses of existing vision-related datasets to explore new scientific ideas and improve understanding of eye health and diseases.

This funding opportunity supports the development of innovative research infrastructure to advance interdisciplinary studies on aging, encouraging collaborations that address complex aging-related issues and health disparities, particularly among women.

The purpose of this notice of funding opportunity (NOFO) is to support basic and exploratory research projects to advance our understanding of T. pallidum bacterial pathogenesis.

This funding opportunity supports innovative projects that develop new technologies for recording and modulating neural activity, aimed at enhancing our understanding of the nervous system through live-animal experimentation.

This grant provides financial support for early-career researchers in dental, oral, and craniofacial fields to receive mentorship and develop their research skills, with a focus on enhancing diversity in the research workforce.

This funding opportunity is designed to support not-for-profit academic medical centers in New York State in establishing telehealth and telementoring programs to improve hepatitis C treatment access for rural and marginalized populations.

This funding opportunity provides $1 million to support a national coordinating center that will enhance collaboration, education, and research initiatives in nonmalignant hematology, targeting a diverse range of eligible institutions.

The Alliance for Pediatric Device Innovation (APDI) is offering grants up to $50,000 for pediatric medical devices aimed at improving the monitoring, diagnosis, or treatment of youth substance use disorders and addiction. Up to $150,000 in total grant funds are available for distribution. Eligible applicants include inventors from established businesses, startups, and academic researchers with commercializable device concepts that address unmet pediatric needs. The goal is to support the development of devices that can be commercialized, with an emphasis on bridging the gap between prototyping and FDA approval, marketing, and sales. Proposals should focus on innovations such as AI-based diagnostic tools, digital therapeutics, wearable devices, and neuromodulation therapies. The application deadline is July 30, 2024, and winners will be announced on August 15, 2024.

This funding opportunity supports community-driven research projects that assess environmental exposures and develop public health interventions to address health disparities in affected communities.